Free Trial
NYSEARCA:LABD

Direxion Daily S&P Biotech Bear 3x Shares (LABD) Price, Holdings, & News

$7.48 +0.04 (+0.54%)
As of 04:10 PM Eastern

About Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD)

Key Stats

Today's Range
$7.25
$7.53
50-Day Range
$6.88
$10.51
52-Week Range
$4.78
$16.05
Volume
12.68 million shs
Average Volume
16.23 million shs
Market Capitalization
$61.08 million
Assets Under Management
$54.07 million
Dividend Yield
3.61%
Net Expense Ratio
1.07%
Aggregate Rating
N/A

ETF Overview

The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion.

Direxion Daily S&P Biotech Bear 3x Shares Expenses

TypeLABDHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.75%0.56%0.56%0.51%0.53%
Other Expenses0.33%0.47%0.56%0.59%0.56%
Total Expense1.08%0.75%0.76%0.74%0.73%
Fee Waiver-0.01%-0.67%-0.66%-0.71%-0.63%
Net Expense1.07%0.60%0.63%0.58%0.60%
Receive LABD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bear 3x Shares and its competitors with MarketBeat's FREE daily newsletter.

LABD ETF News Headlines

TSLL, LABD: Big ETF Outflows
Crypto Is Pumping Again – Now Comes the Real Opportunity
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

LABD ETF - Frequently Asked Questions

Direxion Daily S&P Biotech Bear 3x Shares' stock was trading at $7.25 at the start of the year. Since then, LABD stock has increased by 3.2% and is now trading at $7.48.
View the best growth stocks for 2025 here
.

Direxion Daily S&P Biotech Bear 3x Shares's stock reverse split on the morning of Friday, August 28th 2020.The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of LABD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bear 3x Shares investors own include Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Micron Technology (MU), Direxion Daily S&P Biotech Bull 3x Shares (LABU), NVIDIA (NVDA) and Intel (INTC).

Fund Details

Issuer
Direxion
Fund Name
Direxion Daily S&P Biotech Bear 3x Shares
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:LABD
Inception Date
5/28/2015
Fund Manager
Paul Brigandi, Tony Ng
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
S&P Biotechnology Select Industry Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
16

Fund Statistics

Assets Under Management
$54.07 million
Average Daily Volume
$12.67 million
Discount/Premium
0.00%
Leveraged
-3.00

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Rafferty Asset Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
3,266
Put Options
305
Call Options
2,961
Short Interest
1,410,000 shs

Miscellaneous

Beta
-2.40
Creation Unit
50,000
Creation Fee
$250.00
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Top 9 LABD Holdings

  • Dreyfus Govt Cash Man Ins
    Holding Weight: 52.36%
  • Goldman Sachs Sterling FixInc Port Inc
    Holding Weight: 44.08%
  • Goldman Sachs Fin Gov 465 Institut
    Holding Weight: 18.22%
  • Dreyfus Trsry Securities Cash Mgmt
    Holding Weight: 12.85%
  • Cash
    Holding Weight: -2.83%
  • Citi Collateral
    Holding Weight: -2.99%
  • Baml Collateral
    Holding Weight: -3.89%
  • Goldman Collateral
    Holding Weight: -7.43%
  • S&P Biotechnology Select Industry Index Swap
    Holding Weight: -10.38%

This page (NYSEARCA:LABD) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners